MedPath

HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG

HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG

Approved
DIN Number

02125382

Drug Class

Human

Market Date

Dec 31, 1996

Company
HC

purdue pharma

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02125382
AIG Number0108698012
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA03 HYDROMORPHONE
Product Specifications
Dosage FormCapsule (Sustained-Release)
Route of AdministrationOral
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

HYDROMORPHONE HYDROCHLORIDEActive
Strength: 24 MG
Monograph: HYDROMORPHONE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.